CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Tilray rallies 13% over Germany cannabis legalization and US comments 📈

19:27 22 March 2024

Shares of companies related to the medical marijuana market are seeing euphoric gains today. Shares of Tilray (TLRY.US), Canopy Growth (CGC.US), Aurora Cannabis (ACB.US), and Cronos (CRON.US). Earlier this week, Vice President Kamala Harris spoke optimistically about the U.S. administration's efforts to date to reduce federal regulations. Positive news also came from Germany, which intends to loosen regulations, providing cannabis legalization.

  • Kamala Harris conveyed that the time has come for the US, 'to legalize marijuana.' This represents only a fraction of the broader background, as the key news for the market came from Germany. The first step in this direction is expected to be the deletion of cannabis from its status as a 'narcotic' to a less dangerous substance, as recommended by the U.S. Department of Health and Human Services, 2023.
  • Canopy Growth is trading up nearly 50% today, and has a fairly busy calendar this week, including the prospect of forming a Canopy USA holding company through which it could achieve the rapid legalization of marijuana in America.
  • A Marijuana Moment source pointed out that Germany has passed a bill that will likely fully legalize marijuana, after German lawmakers today refused to take a legal step that would have delayed the process by six months.
  • As a result, marijuana will become legal in Germany on April 1 - legalizing marijuana possession, home cultivation, and distribution to members of "social clubs." Germany's Health Minister Karl Lauterbach confirmed the reports. The next phase of legalization will come when Germany passes legislation standardizing commercial production and retail sales
  • Canopy Growth generates 12% of its revenue from Germany in particular, and is likely to benefit from these changes. The largest U.S. company in the U.S. cannabis market, Tilray generates about 45% of its annual revenue ($285 million) from Europe, the Middle East and Africa (including Germany). Cronos, on the other hand, is less likely to benefit, becasue according to S&P Global Market Intelligence, about 99% of its revenue comes from just two countries: Canada and Israel.


Tilray shares (TLRY.US)

The company's shares are trading up more than 13% today and have broken above the 200-session moving average (red line). 

Start investing today or test a free demo

Open account Try demo Download mobile app Download mobile app

Source: xStation5

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Back
Xtb logo

Join over 1 Million investors from around the world

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
Description
SERVERID
userBranchSymbol cc 2 March 2024
adobe_unique_id cc 1 March 2025
test_cookie cc 1 March 2024
SESSID cc 9 September 2022
__hssc cc 1 March 2024
__cf_bm cc 1 March 2024
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
Description
_gid cc 9 September 2022
_gat_UA-22576382-1 cc 8 September 2022
_gat_UA-121192761-1 cc 8 September 2022
_ga_CBPL72L2EC cc 1 March 2026
_ga cc 1 March 2026
AnalyticsSyncHistory cc 8 October 2022
af_id cc 31 March 2025
afUserId cc 1 March 2026
af_id cc 1 March 2026
AF_SYNC cc 8 March 2024
__hstc cc 28 August 2024
__hssrc

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
Description
MUID cc 26 March 2025
_omappvp cc 11 February 2035
_omappvs cc 1 March 2024
_uetsid cc 2 March 2024
_uetvid cc 26 March 2025
_fbp cc 30 May 2024
fr cc 7 December 2022
muc_ads cc 7 September 2024
lang
_ttp cc 26 March 2025
_tt_enable_cookie cc 26 March 2025
_ttp cc 26 March 2025
hubspotutk cc 28 August 2024

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name
Description
personalization_id cc 7 September 2024
UserMatchHistory cc 8 October 2022
bcookie cc 8 September 2023
lidc cc 9 September 2022
lang
bscookie cc 8 September 2023
li_gc cc 7 March 2023

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence
Language